Home › NDC Lookup › RxCUI directory › RxCUI 1739221

Terbinafine hydrochloride 10 MG/ML Topical Cream [Silka Cream] — RxCUI 1739221

RxNorm drug concept · Semantic branded drug
RxCUI 1739221 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1739221
Official nameTerbinafine hydrochloride 10 MG/ML Topical Cream [Silka Cream]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asSilka 1 % Topical Cream; Silka Cream 10 MG/ML Topical Cream
FDA products mapped2
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Terbinafine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It depends on the form. The tablets treat fungal infections of the toenails or fingernails. Topical products like Lamisil AT treat athlete’s foot, jock itch and ringworm. Your doct...
  • You take one tablet by mouth once a day, with or without food. Fingernails take a shorter course than toenails. Your nail can look better only after healthy nail grows out, which t...
  • Liver failure has happened with terbinafine tablets, even in people with no liver problems. A blood test before and during treatment helps catch trouble early. Call your doctor rig...
  • Headache, diarrhea, rash, upset stomach and itching are the common ones, and they are usually mild. Call your doctor for taste or smell changes, low mood, blistering or spreading r...
📖 Read our full Terbinafine guide →

🕸️ Concept Web — How Terbinafine hydrochloride 10 MG/ML Topical Cream... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Terbinafine hydrochloride 10 MG/ML Topical Cream [Silka Cream] RxCUI 1739221

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Terbinafine 37801
    • Terbinafine hydrochloride 235838
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Silka Cream 1739217
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Terbinafine Topical Cream 377935
    • Terbinafine hydrochloride Topical Cream 2647683
    • Terbinafine Topical Product 1161497
    • Terbinafine hydrochloride Topical Product 2662078
    • Terbinafine Topical Cream [Silka Cream] 1739219
    • Terbinafine hydrochloride Topical Cream [Silka Cream] 2656007
    • Silka Cream Topical Product 1739220
    • Topical Cream 316982
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Terbinafine hydrochloride 10 MG/ML Topical Cream SCD · 992528
  • Terbinafine hydrochloride 10 MG/ML SCDC · 992527
  • Terbinafine Topical Cream SCDF · 377935
  • Terbinafine hydrochloride Topical Cream SCDFP · 2647683
  • Terbinafine Topical Product SCDG · 1161497
  • Terbinafine hydrochloride Topical Product SCDGP · 2662078

Brand-Name Concepts

  • Terbinafine hydrochloride 10 MG/ML [Silka Cream] SBDC · 1739218
  • Terbinafine Topical Cream [Silka Cream] SBDF · 1739219
  • Terbinafine hydrochloride Topical Cream [Silka Cream] SBDFP · 2656007
  • Silka Cream Topical Product SBDG · 1739220
  • Silka Cream BN · 1739217

📦 FDA Products & Package NDCs

2 products · 4 package NDCs
4 package NDCs map to RxCUI 1739221 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50066-0080-02 1 TUBE in 1 CARTON (50066-080-02) / 30 g in 1 TUBE Silka Antifungal Genomma Lab USA, Inc. 2007-07-02
50066-0080-03 1 TUBE in 1 CARTON (50066-080-03) / 30 g in 1 TUBE Silka Antifungal Genomma Lab USA, Inc. 2018-05-21
50066-0080-05 1 TUBE in 1 CARTON (50066-080-05) / 15 g in 1 TUBE Silka Antifungal Genomma Lab USA, Inc. 2018-12-20
50066-0208-05 1 TUBE in 1 CARTON (50066-208-05) / 15 g in 1 TUBE Silka Jock Itch Genomma Lab USA, Inc. 2018-12-20
Observed labelers: Genomma Lab USA, Inc. (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.